Top News
Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins
SBA Member, 27.06.2017
Addex Shareholders Approved all Board Proposals at 2017 Annual General Meeting
GlobeNewswire, 23.06.2017
Novartis Kisqali® (ribociclib) receives positive CHMP opinion as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor
GlobeNewswire, 23.06.2017
Novartis pivotal CTL019 6-month follow-up data show durable remission rates in children, young adults with r/r B-cell ALL
GlobeNewswire, 23.06.2017
Novartis Phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack
GlobeNewswire, 22.06.2017
Santhera's Raxone® Receives First Positive EAMS Scientific Opinion from UK's MHRA in Duchenne Muscular Dystrophy
SBA Member, 22.06.2017
Novartis combination targeted therapy Tafinlar® + Mekinist® receives FDA approval for BRAF V600E mutant metastatic non-small cell lung cancer (NSCLC)
GlobeNewswire, 22.06.2017
Europe, Flanders, the Province of East-Flanders and the City of Ghent invest €9,36 million in the Bio Base Europe Pilot Plant
Biobased Economy, 21.06.2017
Helsinn Group Announces Upcoming Presentation of Phase III data in NEPA (netupitant/palonestron) at MASCC/ISOO Congress in Washington DC
GlobeNewswire, 20.06.2017
Next Events
...
Partners
